Wed, May 12, 2021
Tue, May 11, 2021
Mon, May 10, 2021
Fri, May 7, 2021
Thu, May 6, 2021
Wed, May 5, 2021

Paul Choi Maintained (BBIO) at Strong Buy with Decreased Target to $80 on, May 7th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-80-on-may-7th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Paul Choi of Goldman Sachs, Maintained "BridgeBio Pharma, Inc." (BBIO) at Strong Buy with Decreased Target from $92 to $80 on, May 7th, 2021.

Paul has made no other calls on BBIO in the last 4 months.



There are 3 other peers that have a rating on BBIO. Out of the 3 peers that are also analyzing BBIO, 0 agree with Paul's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Paul


  • Mani Foroohar of "SVB Leerink" Maintained at Buy with Increased Target to $75 on, Tuesday, March 23rd, 2021
  • Salim Syed of "Mizuho" Maintained at Strong Buy with Increased Target to $86 on, Thursday, March 4th, 2021
  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $87 on, Monday, January 11th, 2021

Publication Contributing Sources